SELLAS Life Sciences Group, Inc. Operating Leases, Rent Expense
SELLAS Life Sciences Group, Inc. (SLS) reported Operating Leases, Rent Expense of $300.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2020-03-13
- SELLAS Life Sciences Group, Inc. operating leases, rent expense for the quarter ending 2018-03-31 was $100.00K.
- SELLAS Life Sciences Group, Inc. operating leases, rent expense for fiscal 2018 was $300.00K, a 50.00% increase from fiscal 2017.
- SELLAS Life Sciences Group, Inc. operating leases, rent expense for fiscal 2017 was $200.00K, a 0.00% change from fiscal 2016.
- SELLAS Life Sciences Group, Inc. operating leases, rent expense for fiscal 2016 was $200.00K.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 12 month |
|---|---|---|
| 2018-12-31 | $300.00K 10-K · filed 2020-03-13 | |
| 2018-03-31 | $100.00K 10-Q · filed 2019-05-15 | |
| 2017-12-31 | $200.00K 10-K · filed 2019-03-22 | |
| 2016-12-31 | $200.00K 10-K · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |